Concanavalin A-induced activation of thymus cells compared to spleen or lymph node activation is extremely sensitive to the inhibitory effect of hydrocortisone (HC). This inhibitory effect of thymus cells, as observed at concentrations of 10(-7) M and higher, can be abrogated (at concentrations of up to 10(-5) M HC) by the addition of culture supernatants containing the product of activated T cells--Interleukin 2 (IL2), but not the supernatants containing the product of activated macrophages--Interleukin 1 (IL1). The protective effect of the IL2-containing supernatants can in part be removed by absorption with T cell blasts, but not B cell blasts. These results support the following notion of the mechanism of T cell activation. IL1 induces IL2 production by helper T cells and IL2, in turn, initiates proliferation of the sensitive T cells with IL2 receptors. These observations suggest that the inhibitory effect of HC on thymus cell activation results from inhibition of IL2 production.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0192-0561(82)90013-3DOI Listing

Publication Analysis

Top Keywords

thymus cells
12
inhibitory hydrocortisone
8
concanavalin a-induced
8
a-induced activation
8
activation thymus
8
inhibitory thymus
8
supernatants product
8
product activated
8
cell blasts
8
cell activation
8

Similar Publications

Dendritic cells (DCs), the primary antigen-presenting cells, have traditionally been identified by CD103 molecules in rats, whereas mouse and human DCs are identified by CD11c molecules. However, this history does not preclude the existence of CD103 DCs in rats. To explore this possibility, we examined MHCII cells in rat spleen and thymus, identifying a novel population of CD103MHCIICD45RCD172a cells.

View Article and Find Full Text PDF

Background: Mucopolysaccharidosis type I (MPS I - IDUA gene) is a rare autosomal recessive lysosomal storage disorder. Clinical symptoms, including visceral overload, are progressive and typically begin postnatally. Descriptions of hepatosplenomegaly associated with lysosomal pathology are uncommon during the prenatal period.

View Article and Find Full Text PDF

In this study, novel 2-styrylquinoline derivatives possessing a planar aromatic system and a flexible side chain with an amino substituent were designed and synthesized as DNA-intercalating antitumor agents. The cytotoxic activity of the synthesized compounds was evaluated against four cancer cell lines including MCF-7 (breast cancer cells), A549 (lung epithelial cancer cells), HCT116 (colon cancer cells) and normal cell line L929 (mouse fibroblast cell line). The results displayed that the anti-cancer activity of the target quinolines is sensitive to the lipophilic nature of the C-6 and C-7 quinoline substituents.

View Article and Find Full Text PDF

The photo-induced CO-releasing properties of the dark-stable complex [RuCl(CO)L] (L = 2-(pyridin-2-yl)quinoxaline) were investigated under 468 nm light exposure in the presence and absence of biomolecules such as histidine, calf thymus DNA and hen egg white lysozyme. The CO release kinetics were consistent regardless of the presence of these biomolecules, suggesting that they did not influence the CO release mechanism. The quinoxaline ligand demonstrated exceptional cytotoxicity against human acute monocytic leukemia cells (THP-1), with evidence of potential DNA damage ascertained by comet assay, while it remained non-toxic to normal kidney epithelial cells derived from African green monkey (Vero) cell lines.

View Article and Find Full Text PDF

Donor MHC-specific thymus vaccination allows for immunocompatible allotransplantation.

Cell Res

January 2025

Translational Medical Center for Stem Cell Therapy, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.

Organ transplantation is the last-resort option to treat organ failure. However, less than 10% of patients benefit from this only option due to lack of major histocompatibility complex (MHC)-matched donor organs and 25%-80% of donated organs could not find MHC-matched recipients. T cell allorecognition is the principal mechanism for allogeneic graft rejection.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!